Goddard Glenn (CIK 0001581992)

Latest company ownership

Shares held
41,316
Last filed at
Mar 5, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
856
Last filed at
Sep 28, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 3, 2024 Jan 5, 2024 Intellia Therapeutics, Inc. CFO Sell 42.5 -5,365 -11.68% ✗ $158.1K
Jan 4, 2023 Jan 6, 2023 Intellia Therapeutics, Inc. CFO Sell 42.5 -2,427 -13.61% ✗ $90.3K
Jan 1, 2022 Mar 3, 2022 Intellia Therapeutics, Inc. CFO Sell 95.0 +11,707 382.33% ✗ $113.7K
Sep 7, 2021 Sep 9, 2021 Intellia Therapeutics, Inc. CFO Sell 7.5 -3,482 -100.00% ✓ $627.2K
Aug 30, 2021 Sep 1, 2021 Intellia Therapeutics, Inc. CFO Sell 5.0 -30,000 -70.12% ✓ $4.8M
Aug 5, 2021 Aug 6, 2021 Intellia Therapeutics, Inc. CFO Sell 5.0 -20,000 -100.00% ✓ $3M
Sep 24, 2015 Sep 28, 2015 AGIOS PHARMACEUTICALS, INC. President Sell 7.5 -10,856 -67.85% ✓ $947.5K
Jul 23, 2015 Jul 27, 2015 AGIOS PHARMACEUTICALS, INC. President Sell 7.5 -7,000 -100.00% ✓ $843.2K
Jul 17, 2015 Jul 21, 2015 AGIOS PHARMACEUTICALS, INC. President Sell 5.0 -13,000 -100.00% ✓ $1.5M
May 27, 2015 May 28, 2015 AGIOS PHARMACEUTICALS, INC. President Sell 7.5 -2,171 -100.00% ✓ $260.6K
Mar 16, 2015 Mar 18, 2015 AGIOS PHARMACEUTICALS, INC. President Sell 5.0 -10,000 -100.00% ✓ $1.1M
Feb 13, 2015 Feb 17, 2015 AGIOS PHARMACEUTICALS, INC. President Sell 10.0 -1,316 -100.00% ✓ $158.3K